Secondary prevention of coronary heart disease in elderly population of turkey: A subgroup analysis of Elderturk study

Basit Öğe Kaydı
dc.contributor.authorKılıç, Salih
dc.contributor.authorSümerkan, Mutlu Çağan
dc.contributor.authorEmren, Sadık Volkan
dc.contributor.authorBekar, Lütfü
dc.contributor.authorÇerşit, Sinan
dc.contributor.authorTunç, Elif
dc.contributor.authorGök, Gülay
dc.contributor.authorAltuntaş, Emine
dc.contributor.authorCanpolat, Uğur
dc.contributor.authorSinan, Ümit Yaşar
dc.contributor.authorÖzmen, Namık
dc.contributor.authorZoghi, Mehdi
dc.date.accessioned2019-05-13T09:07:17Z
dc.date.available2019-05-13T09:07:17Z
dc.date.issued2019
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractBackground: Secondary prevention plays an important role after acute coronary event due to high risk of adverse events in elderly. In present study we aimed to evaluate the lifestyle, management of risk factors and medical treatment for secondary protection in elderly patients with known coronary heart disease (CHD). Methods: ELDERTURK is a non-interventional, multi-centered, observational study, which included total of 5694 elderly patients (> 65 years) from 50 centers in Turkey. In this study elderly patients from the ELDERTURK population with known CHD were evaluated for cardiovascular risk factors, comorbidities and medication usage. Results: A total of 2976 (52.3% of study) out of 5694 patients included in the ELDERTURK study were evaluated. All had known CHD with a mean age of 73.4 ± 6.2 years and 60.3% were male. 13.0% of patients were smokers, 42.4% were overweight and 21.1% were obese. Only 23.6% of patients reported to do regular exercise, 73.4% had history of hypertension, 47.4% had dyslipidemia and 33.9% had diabetes mellitus. The rate of patients with systolic blood pressure > 140 mmHg were 31.1% and only 13.9% of patients had a recommended ? 70 mg/dL level of low-density lipoprotein cholesterol. Antiplatelet, statin, beta-blocker and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker usage was limited to 27.3%. Conclusions: The ELDERTURK study shows that many patients with CHD have a high prevalence of modifiable risk factors and unhealthy lifestyle. Apart from this, many patients are not receiving therapeutic intervention and as a consequence most were not achieving the recommended goals. © 2019 Via Medica.
dc.identifier.citationKılıç, S., Sümerkan, M. Ç., Emren, V., Bekar, L., Çerşit, S., Tunç, E., Gök, G., Altuntaş, E. [et al.]. (2019). Secondary prevention of coronary heart disease in elderly population of Turkey: A subgroup analysis of ELDERTURK study. Cardiology Journal, 26(1), 13-19.
dc.identifier.doi10.5603/CJ.a2017.0113
dc.identifier.endpage19en_US
dc.identifier.issn1897-5593
dc.identifier.issue1en_US
dc.identifier.scopusqualityQ2
dc.identifier.startpage13en_US
dc.identifier.urihttps://doi.org/10.5603/CJ.a2017.0113
dc.identifier.urihttps://hdl.handle.net/11491/1769
dc.identifier.volume26en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherVia Medica
dc.relation.ispartofCardiology Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAgingen_US
dc.subjectCoronary Diseaseen_US
dc.subjectDrugsen_US
dc.subjectEpidemiologyen_US
dc.subjectPreventionen_US
dc.subjectTreatmenten_US
dc.titleSecondary prevention of coronary heart disease in elderly population of turkey: A subgroup analysis of Elderturk study
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Bekar, Lütfü.pdf
Boyut:
233.97 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu